Delivery Order SPE2DB20D1047-SPE2DB25FF72K
- Not listed
- This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $7,416.27 firm fixed-price delivery order contract was awarded on July 11, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of July 14, 2025. The contract is not set-aside and allows for the supply of prescription medications, medical devices, and other healthcare-related...
- This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,770.74 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- The federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,283.17 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with an ultimate completion date of July 17, 2025. This delivery order contract is not a set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract, valued at $1,645.62, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a firm fixed-price delivery order with a completion date of July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 15, 2024 with a completion date of July 16, 2024. The contract has a firm fixed price ceiling value of $3,049.48. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,228.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The federal contract award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,990.64, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of June 4, 2024. This contract award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,097.08, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of March 12, 2024. This award is a delivery order under Amerisourcebergen's...
- This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $4,310.09 firm fixed-price delivery order was competitively awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,097.08 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 18, 2024 and was not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF72KDelivery Order
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $5,323.50 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 16, 2025, with a completion date of July 17, 2025. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the agency. This contract award is likely part of that larger IDC program, enabling Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 7/16/25 |